Inventor
HORNBERGER KEITH R
US20 patents
⚠️ This page may combine multiple inventors who share the name “HORNBERGER KEITH R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARVINAS OPERATIONS INC
15 patentsUS11104666B2Aug 31, 2021
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC18 citations94
US11173211B2Nov 16, 2021
Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides
ARVINAS OPERATIONS INC6 citations84
US12077509B2Sep 3, 2024
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC1 citations73
US11964945B2Apr 23, 2024
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC2 citations73
US11161841B2Nov 2, 2021
Modulators of proteolysis and associated methods of use
ARVINAS OPERATIONS INC3 citations73
US12552783B2Feb 17, 2026
Modulators of proteolysis and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US12275716B2Apr 15, 2025
Modulators of estrogen receptor proteolysis and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US12239711B2Mar 4, 2025
Cereblon ligands and bifunctional compounds comprising the same
ARVINAS OPERATIONS INC0 citations62
US12180193B2Dec 31, 2024
Accelerating fibrosarcoma protein degrading compounds and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US12172981B2Dec 24, 2024
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC0 citations62
US11986531B2May 21, 2024
Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides
ARVINAS OPERATIONS INC0 citations62
US12156916B2Dec 3, 2024
Rapid accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use
ARVINAS OPERATIONS INC0 citations61
US11957759B1Apr 16, 2024
Rapidly accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use
ARVINAS OPERATIONS INC0 citations61
US10806737B2Oct 20, 2020
Compounds and methods for the targeted degradation of fetal liver kinase polypeptides
ARVINAS OPERATIONS INC2 citations60
US12441708B2Oct 14, 2025
Cereblon ligands and bifunctional compounds comprising the same
ARVINAS OPERATIONS INC0 citations52